Location History:
- Beijing, CN (2020)
- Qinghai, CN (2021)
- Xining, CN (2023)
Company Filing History:
Years Active: 2020-2023
Title: Lixin Wei: Innovator in Pharmaceutical Advancements
Introduction
Lixin Wei is a prominent inventor based in Qinghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative medicaments. With a total of 3 patents to his name, Wei's work focuses on enhancing drug delivery and mitigating side effects associated with cancer treatments.
Latest Patents
Wei's latest patents include groundbreaking research on the use of gTso thal in manufacturing a medicament that promotes MS-275 to cross the blood-brain barrier. This invention is crucial as it significantly increases the accumulation of MS-275 in brain tissue, thereby enhancing its therapeutic effects. Another notable patent involves the application of an anthocyanin extract in preparing a pharmaceutical composition aimed at preventing and treating cardiac toxicity induced by anthracyclines. This composition not only demonstrates protective effects against cardiomyocyte toxicity but also offers a safe and cost-effective solution for patients undergoing chemotherapy.
Career Highlights
Lixin Wei is affiliated with the Chinese Academy of Sciences, where he conducts his research and development activities. His work has garnered attention for its potential to improve patient outcomes in cancer treatment and other medical applications.
Collaborations
Wei collaborates with esteemed colleagues, including Xiaohui Zhao and Ting Ting Zhang, to further advance his research initiatives. Their combined expertise contributes to the innovative solutions being developed in the pharmaceutical field.
Conclusion
Lixin Wei's contributions to pharmaceutical innovations highlight the importance of research in improving drug efficacy and safety. His patents reflect a commitment to enhancing patient care through scientific advancements.